Having too much body fat can threaten brain health in multiple ways: It can increase the odds of developing high blood pressure, type 2 diabetes, and unhealthy blood fats.
Moreover, a study by FPN’s Scientific Advisor, Eva Feldman, MD, PhD, FAAN, published in the Journal of Neuroscience in May 2021, linked saturated fat and obesity to peripheral neuropathy.
NIH-Funded Study Shows Promise in Slowing Disease Progression
Researchers have identified a pathway common to several types of axonal peripheral neuropathies (APNs), including multiple forms of Charcot-Marie-Tooth (CMT) disease, and have identified a possible drug target that could help treat the disorder.
The study was funded in part by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.
Efficacy of Gabapentin and Duloxetine for Painful PN
According to a recent study published in The International Journal of Clinical Practice, there is no significant difference between the use of gabapentin or duloxetine for the treatment of painful diabetic peripheral neuropathy.
Spinal Cord Stimulation OK’d for Diabetic Nerve Pain
The FDA approved the first spinal cord stimulation device (HFX) for painful diabetic neuropathy (PDN), Nevro Corp announced in July 2021.
Cancer Survivors: Mindfulness Meditation Survey
The University of Hawaii Cancer Center is currently asking for cancer survivors with cancer-related neuropathy to participate in a study on using mindfulness meditation to potentially reduce symptoms.
To learn more about this study and if you qualify, click here.
The Foundation for Peripheral Neuropathy provides education and support today as we walk toward a cure for tomorrow.
Support us in advancing a cure!
FPN is a non-profit organization that is solely funded by our readers.